tissue-based diagnostics Lung Cancer Study Suggests Liquid Biopsy Reduces Treatment Delays, Boosts Target Detection A clinical trial suggests circulating tumor DNA genotyping prior to tissue-based diagnoses can reduce time to treatment in advanced NSCLC patients. Foundation Medicine Probing Tumor Fraction Influence on Negative Liquid Biopsies Premium The company has published evidence that its TF estimation technique could potentially guide clinical follow-up decisions in cases with a negative liquid biopsy result. Fulgent Genetics Preliminary Q1 Revenues Exceed Guidance; Firm to Acquire Inform Diagnostics Fulgent plans to leverage the Texas-based pathology lab's established commercial organization and managed care relationships. Qiagen, Mirati Therapeutics Partner to Develop KRAS Companion Test for NSCLC Drug The tissue-based test will identify cancer patients who may benefit from adagrasib, Mirati's investigational oral small molecule inhibitor of KRAS G12C. UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing Premium Spun out of the Glasgow Precision Oncology Laboratory, Gabriel wants targeted sequencing to become the norm for all somatic cancer patients. May 13, 2020 Representative Tumor Sampling Method Promises to Lessen Bias of Molecular Analyses Premium Apr 27, 2020 FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics Feb 10, 2020 Through Mayo Clinic Pact, PGDx Hopes to Show Clinical Utility for NGS Tissue, Liquid Biopsy Assays Premium Jan 15, 2020 JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex Jul 25, 2019 Roche Reports Flat Diagnostics Revenues in H1 Apr 17, 2019 Roche Reports Flat Q1 Diagnostics Sales Jan 19, 2018 RNA Hybridization, Multiplex Assays Central to Bio-Techne's Growth Plans Premium Dec 9, 2016 Novartis PI3K Inhibitor Effective in Breast Cancer Subset; Psych Toxicities Dampen Enthusiasm Premium Jul 15, 2016 Ethics, Guidelines for Molecular Autopsy in Youth Sudden Death Explored by Texas Team Dec 23, 2014 Now Part of AstraZeneca, Definiens Concentrating on CDx, Ramp up into Clinical Space Premium Dec 10, 2014 Roche Buys Tissue Dissection Technology from AvanSci Bio Jun 23, 2014 Definiens Raises $20.4M in Private Financing Round Jun 25, 2013 TGen, Ventana Ink Pancreatic Cancer Biomarker Pact Mar 12, 2013 Leica, Synthon Biopharmaceuticals Partner on CDx Development Feb 15, 2013 FDA Clears ASI Gene Scanner as PGx Tool for NSCLC Feb 12, 2013 Dako, Pfizer Reach Companion Dx Deal Sep 6, 2012 Agilent Discloses Dako Earnings May 17, 2012 Agilent Buying Cancer Diagnostics Company Dako for $2.2B May 1, 2012 Dako, Genentech Partner on Regulatory Submission of CDx for Second Breast Cancer Drug Apr 30, 2012 GE Grant Funds Moffitt Breast Cancer Metastasis Marker Study Load More Breaking News SARS-CoV-2 Variants of Concerns Evolved to Modify Host Immune Response, Multiomics Study Shows People in the News at GA4GH, Mercy BioAnalytics, Deepcell, One Biosciences New Products Posted to GenomeWeb: Clinical Microbiomics, Integra Biosciences, DNAstack, Bruker Angolan Namib Desert Population Analysis Uncovers New Ancestry Group With Deep Divergence Cedars-Sinai Sets Up $25M Single Cell Precision Medicine Center The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.